scholarly journals Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance

Obesity ◽  
2011 ◽  
Vol 19 (7) ◽  
pp. 1404-1414 ◽  
Author(s):  
Louis J. Aronne ◽  
Nick Finer ◽  
Priscilla A. Hollander ◽  
Richard D. England ◽  
Solomon S. Klioze ◽  
...  
Keyword(s):  
Weight Loss ◽  
Receptor Antagonist ◽  
Cb1 Receptor ◽  
Efficacy And Safety ◽  
Cannabinoid Cb1 Receptor ◽  
Cb1 Receptor Antagonist ◽  
Cannabinoid Cb1 Receptor Antagonist

scholarly journals Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

2009 ◽  
Vol 29 (1) ◽  
pp. 12-18 ◽  
Author(s):  
Frédérique Dol-Gleizes ◽  
Réjane Paumelle ◽  
Virgile Visentin ◽  
Anne-Marie Marés ◽  
Perrine Desitter ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Ldl Receptor ◽  
Cb1 Receptor ◽  
Cannabinoid Cb1 Receptor ◽  
Cb1 Receptor Antagonist ◽  
Deficient Mice ◽  
Cannabinoid Cb1 Receptor Antagonist

scholarly journals Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant

2008 ◽  
Vol 33 (12) ◽  
pp. 2870-2877 ◽  
Author(s):  
Zuzana Justinova ◽  
Patrik Munzar ◽  
Leigh V Panlilio ◽  
Sevil Yasar ◽  
Godfrey H Redhi ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Cb1 Receptor ◽  
Cannabinoid Cb1 Receptor ◽  
Seeking Behavior ◽  
Cb1 Receptor Antagonist ◽  
Cannabinoid Cb1 Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document